Dong-Hui Huang, Lei Wang, Xiao-Ying Li, Ying Qin, Fang-Hua Liu, Yi-Zi Li, He-Li Xu, Fan Cao, Lang Wu, Yi-Fan Wei, Song Gao, Ting-Ting Gong, Yu-Hong Zhao, Qi-Jun Wu
{"title":"Pre- and post-diagnosis dietary total antioxidant capacity and overall survival in patients with ovarian cancer: a prospective cohort study.","authors":"Dong-Hui Huang, Lei Wang, Xiao-Ying Li, Ying Qin, Fang-Hua Liu, Yi-Zi Li, He-Li Xu, Fan Cao, Lang Wu, Yi-Fan Wei, Song Gao, Ting-Ting Gong, Yu-Hong Zhao, Qi-Jun Wu","doi":"10.1186/s12937-025-01185-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The current study aims to investigate the association between dietary total antioxidant capacity (DTAC) and overall survival (OS) in patients with ovarian cancer (OC).</p><p><strong>Methods: </strong>A validated 111-item food frequency questionnaire was used to assess their pre- and post-diagnosis dietary intake. DTAC is represented by ferric-reducing ability of plasma (FRAP), total oxygen radical absorbance capacity (TORAC), hydrophilic oxygen radical absorbance capacity (HORAC), lipophilic oxygen radical absorbance capacity (LORAC), and total phenolics (TP). The OS was determined by both passive and active follow-up.</p><p><strong>Results: </strong>A total of 531 patients with OC was involved in this study. High post-diagnosis FRAP (HR<sub>T3 vs. T1</sub>=0.65, 95%CI = 0.42-0.99), post-diagnosis TORAC (HR<sub>T3 vs. T1</sub>=0.68, 95%CI = 0.47-0.98), and pre-diagnosis LORAC (HR<sub>T3 vs. T1</sub>=0.62, 95%CI = 0.43-0.89) had statistically significant association with an improved OS. Additionally, increased DTAC consumption (FRAP: HR <sub>Low-Medium</sub>=0.53, 95%CI = 0.30-0.95; FRAP: HR <sub>Low-High</sub>=0.46, 95%CI = 0.23-0.93; LORAC: HR <sub>Medium-High</sub>=0.50, 95%CI = 0.27-0.91), as well as maintaining high or medium DTAC consumption (TORAC: HR <sub>Medium-Medium</sub>=0.46, 95%CI = 0.26-0.83; TORAC: HR <sub>High-High</sub>=0.57, 95%CI = 0.34-0.96; LORAC: HR <sub>High-Medium</sub>=0.43, 95%CI = 0.23-0.82), improved the OS in patients with OC.</p><p><strong>Conclusions: </strong>Increased pre- and post-diagnosis DTAC intake, and maintaining moderate or high DTAC intake after diagnosis, may be associated with enhanced OS in patients with OC.</p>","PeriodicalId":19203,"journal":{"name":"Nutrition Journal","volume":"24 1","pages":"122"},"PeriodicalIF":3.8000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12315226/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nutrition Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12937-025-01185-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The current study aims to investigate the association between dietary total antioxidant capacity (DTAC) and overall survival (OS) in patients with ovarian cancer (OC).
Methods: A validated 111-item food frequency questionnaire was used to assess their pre- and post-diagnosis dietary intake. DTAC is represented by ferric-reducing ability of plasma (FRAP), total oxygen radical absorbance capacity (TORAC), hydrophilic oxygen radical absorbance capacity (HORAC), lipophilic oxygen radical absorbance capacity (LORAC), and total phenolics (TP). The OS was determined by both passive and active follow-up.
Results: A total of 531 patients with OC was involved in this study. High post-diagnosis FRAP (HRT3 vs. T1=0.65, 95%CI = 0.42-0.99), post-diagnosis TORAC (HRT3 vs. T1=0.68, 95%CI = 0.47-0.98), and pre-diagnosis LORAC (HRT3 vs. T1=0.62, 95%CI = 0.43-0.89) had statistically significant association with an improved OS. Additionally, increased DTAC consumption (FRAP: HR Low-Medium=0.53, 95%CI = 0.30-0.95; FRAP: HR Low-High=0.46, 95%CI = 0.23-0.93; LORAC: HR Medium-High=0.50, 95%CI = 0.27-0.91), as well as maintaining high or medium DTAC consumption (TORAC: HR Medium-Medium=0.46, 95%CI = 0.26-0.83; TORAC: HR High-High=0.57, 95%CI = 0.34-0.96; LORAC: HR High-Medium=0.43, 95%CI = 0.23-0.82), improved the OS in patients with OC.
Conclusions: Increased pre- and post-diagnosis DTAC intake, and maintaining moderate or high DTAC intake after diagnosis, may be associated with enhanced OS in patients with OC.
期刊介绍:
Nutrition Journal publishes surveillance, epidemiologic, and intervention research that sheds light on i) influences (e.g., familial, environmental) on eating patterns; ii) associations between eating patterns and health, and iii) strategies to improve eating patterns among populations. The journal also welcomes manuscripts reporting on the psychometric properties (e.g., validity, reliability) and feasibility of methods (e.g., for assessing dietary intake) for human nutrition research. In addition, study protocols for controlled trials and cohort studies, with an emphasis on methods for assessing dietary exposures and outcomes as well as intervention components, will be considered.
Manuscripts that consider eating patterns holistically, as opposed to solely reductionist approaches that focus on specific dietary components in isolation, are encouraged. Also encouraged are papers that take a holistic or systems perspective in attempting to understand possible compensatory and differential effects of nutrition interventions. The journal does not consider animal studies.
In addition to the influence of eating patterns for human health, we also invite research providing insights into the environmental sustainability of dietary practices. Again, a holistic perspective is encouraged, for example, through the consideration of how eating patterns might maximize both human and planetary health.